Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hwang Gyun Jeon

Showing results (141-150 of 182) with videos related to

Pageof 19
Sort By:
Plos One|June 8, 2022
Correction: Biochemical recurrence after radical prostatectomy according to nadir prostate specific antigen valueJae Hoon Chung, Jae Yong Jeong, Ji Youl Lee, et al.
Cancers|September 9, 2022
Clinical Utility of Prostate Health Index for Diagnosis of Prostate Cancer in Patients with PI-RADS 3 LesionsChung-Un Lee, Sang-Min Lee, Jae-Hoon Chung, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 4, 2014
Suggestion for the prostatic fossa clinical target volume in adjuvant or salvage radiotherapy after a radical prostatectomyJun Su Park, Won Park, Hong Ryull Pyo, et al.
World Journal of Urology|October 15, 2016
Accuracy of preoperative multiparametric magnetic resonance imaging for prediction of unfavorable pathology in patients with localized prostate cancer undergoing radical prostatectomyHakmin Lee, Chan Kyo Kim, Byung Kwan Park, et al.
Korean Journal of Urology|December 17, 2014
Location of positive surgical margin and its association with biochemical recurrence rate do not differ significantly in four different types of radical prostatectomyYoon Seok Suh, Hyeon Jun Jang, Wan Song, et al.
Acta Haematologica|December 22, 2012
Placenta-derived mesenchymal stem cells have an immunomodulatory effect that can control acute graft-versus-host disease in miceMoon Ju Jang, Hye-Sun Kim, Hye-Gyn Lee, et al.
Korean Journal of Urology|March 1, 2014
High-intensity focused ultrasound as salvage therapy for patients with recurrent prostate cancer after radiotherapyWan Song, U Seok Jung, Yoon Seok Suh, et al.
Cancer Management and Research|September 2, 2024
Prognostic Role of Pre-Treatment Body Composition Parameters in Patients Undergoing First-Line Immunotherapy for Metastatic Renal Cell CarcinomaSangmin Lee, Jae-Hun Kim, Wan Song, et al.
The Prostate|January 24, 2019
A randomized, double-blind, placebo-controlled trial to evaluate the role of curcumin in prostate cancer patients with intermittent androgen deprivationYoung Hyo Choi, Deok Hyun Han, Seon-Woo Kim, et al.
Scientific Reports|March 11, 2021
Potential of circulating tumor DNA as a predictor of therapeutic responses to immune checkpoint blockades in metastatic renal cell carcinomaYeon Jeong Kim, Yumi Kang, Jun Seop Kim, et al.
Pageof 19

Showing results (141-150 of 182) with videos related to

Sort By:
Pageof 19
Plos One|June 8, 2022
Correction: Biochemical recurrence after radical prostatectomy according to nadir prostate specific antigen valueJae Hoon Chung, Jae Yong Jeong, Ji Youl Lee, et al.
Cancers|September 9, 2022
Clinical Utility of Prostate Health Index for Diagnosis of Prostate Cancer in Patients with PI-RADS 3 LesionsChung-Un Lee, Sang-Min Lee, Jae-Hoon Chung, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 4, 2014
Suggestion for the prostatic fossa clinical target volume in adjuvant or salvage radiotherapy after a radical prostatectomyJun Su Park, Won Park, Hong Ryull Pyo, et al.
World Journal of Urology|October 15, 2016
Accuracy of preoperative multiparametric magnetic resonance imaging for prediction of unfavorable pathology in patients with localized prostate cancer undergoing radical prostatectomyHakmin Lee, Chan Kyo Kim, Byung Kwan Park, et al.
Korean Journal of Urology|December 17, 2014
Location of positive surgical margin and its association with biochemical recurrence rate do not differ significantly in four different types of radical prostatectomyYoon Seok Suh, Hyeon Jun Jang, Wan Song, et al.
Acta Haematologica|December 22, 2012
Placenta-derived mesenchymal stem cells have an immunomodulatory effect that can control acute graft-versus-host disease in miceMoon Ju Jang, Hye-Sun Kim, Hye-Gyn Lee, et al.
Korean Journal of Urology|March 1, 2014
High-intensity focused ultrasound as salvage therapy for patients with recurrent prostate cancer after radiotherapyWan Song, U Seok Jung, Yoon Seok Suh, et al.
Cancer Management and Research|September 2, 2024
Prognostic Role of Pre-Treatment Body Composition Parameters in Patients Undergoing First-Line Immunotherapy for Metastatic Renal Cell CarcinomaSangmin Lee, Jae-Hun Kim, Wan Song, et al.
The Prostate|January 24, 2019
A randomized, double-blind, placebo-controlled trial to evaluate the role of curcumin in prostate cancer patients with intermittent androgen deprivationYoung Hyo Choi, Deok Hyun Han, Seon-Woo Kim, et al.
Scientific Reports|March 11, 2021
Potential of circulating tumor DNA as a predictor of therapeutic responses to immune checkpoint blockades in metastatic renal cell carcinomaYeon Jeong Kim, Yumi Kang, Jun Seop Kim, et al.
Pageof 19